Marimed (MRMD) Retained Earnings (2011 - 2026)

Marimed (MRMD) has 16 years of Retained Earnings data on file, last reported at -$131.7 million in Q1 2026.

• Retained Earnings for Q1 2026 came in at -$131.7 million, down 12.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$131.7 million (down 12.03% YoY), and the FY2025 annual result was -$127.9 million, down 12.77% from the prior year.
• Retained Earnings retreated to -$131.7 million in Q1 2026 per MRMD's latest filing, from -$127.9 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$83.9 million in Q4 2022 and troughed at -$131.7 million in Q1 2026.
• A 5-year average of -$103.4 million and a median of -$101.3 million in 2024 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2024: Retained Earnings rose 13.83% in 2022, then dropped 20.32% in 2024.
• A 5-year view of Retained Earnings shows it stood at -$83.9 million in 2022, then declined by 19.1% to -$100.0 million in 2023, then slipped by 13.5% to -$113.4 million in 2024, then retreated by 12.77% to -$127.9 million in 2025, then decreased by 2.96% to -$131.7 million in 2026.
• Business Quant data shows MRMD's Retained Earnings at -$131.7 million in Q1 2026, -$127.9 million in Q4 2025, and -$123.3 million in Q3 2025.